...indication in 1Q19. Realm said it will provide an update on its plans next month. Realm Therapeutics plc... ...and pruritus Numerical Rating Scale (NRS) scores Status: Preliminary Phase II data Milestone: NA
Jaime De Leon
PR022
Realm Therapeutics plc...
...redness as measured by the Ora Calibra Ocular Hyperemia Scale on days seven to eight. Realm Therapeutics plc... ...Calibra Ocular Hyperemia Scale on days seven to eight Status: Development discontinued Milestone: NA
Jaime De Leon
PR013
Realm Therapeutics plc...
...scores. PR022 is a topical gel formulation containing a high dose concentration of hypochlorous acid. Realm Therapeutics plc... ...pruritus Numerical Rating Scale (NRS) scores Status: Phase II started Milestone: Phase II data (3Q18)
Allison Johnson
PR022
Realm Therapeutics plc...
...On Sept. 21, dermatology and ophthalmology company Realm Therapeutics plc (LSE:RLM) raised £19.3 million ($26.2 million) through the... ...solution formulations, respectively, containing a high concentration of hypochlorous acid. Realm Therapeutics plc (LSE:RLM), Malvern, Pa.
Elizabeth S. Eaton
PR013
PR022
Realm Therapeutics plc...
...Dermatology and ophthalmology company Realm Therapeutics plc (LSE:RLM) raised £19.3 million ($26.2 million) through the sale of 66.4... ...containing a high concentration of hypochlorous acid. Realm was unchanged at 29.50p on Thursday.
Elizabeth S. Eaton
PR013
PR022
Realm Therapeutics plc...
...dermatology subsidiary Onset Dermatologics to develop and manufacture a dermatologic hydrogel to treat atopic dermatitis. PuriCore... ...product, which Onset will exclusively market and distribute in the U.S. as Aurstat Anti-Itch Hydrogel. PuriCore... ...of its Vashe technology. The 510(k) clearance triggered an undisclosed milestone to PuriCore from Onset. PuriCore...
...indication in 1Q19. Realm said it will provide an update on its plans next month. Realm Therapeutics plc... ...and pruritus Numerical Rating Scale (NRS) scores Status: Preliminary Phase II data Milestone: NA
Jaime De Leon
PR022
Realm Therapeutics plc...
...redness as measured by the Ora Calibra Ocular Hyperemia Scale on days seven to eight. Realm Therapeutics plc... ...Calibra Ocular Hyperemia Scale on days seven to eight Status: Development discontinued Milestone: NA
Jaime De Leon
PR013
Realm Therapeutics plc...
...scores. PR022 is a topical gel formulation containing a high dose concentration of hypochlorous acid. Realm Therapeutics plc... ...pruritus Numerical Rating Scale (NRS) scores Status: Phase II started Milestone: Phase II data (3Q18)
Allison Johnson
PR022
Realm Therapeutics plc...
...On Sept. 21, dermatology and ophthalmology company Realm Therapeutics plc (LSE:RLM) raised £19.3 million ($26.2 million) through the... ...solution formulations, respectively, containing a high concentration of hypochlorous acid. Realm Therapeutics plc (LSE:RLM), Malvern, Pa.
Elizabeth S. Eaton
PR013
PR022
Realm Therapeutics plc...
...Dermatology and ophthalmology company Realm Therapeutics plc (LSE:RLM) raised £19.3 million ($26.2 million) through the sale of 66.4... ...containing a high concentration of hypochlorous acid. Realm was unchanged at 29.50p on Thursday.
Elizabeth S. Eaton
PR013
PR022
Realm Therapeutics plc...
...dermatology subsidiary Onset Dermatologics to develop and manufacture a dermatologic hydrogel to treat atopic dermatitis. PuriCore... ...product, which Onset will exclusively market and distribute in the U.S. as Aurstat Anti-Itch Hydrogel. PuriCore... ...of its Vashe technology. The 510(k) clearance triggered an undisclosed milestone to PuriCore from Onset. PuriCore...